<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:bir="http://www.alacra.com/bir" xmlns:ccbn="http://www.alacra.com/ccbn" xmlns:newstex="http://www.alacra.com/newstex" ><channel><title>Medicines Company, The RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>Medicines Company, The</description>
<link>http://www.alacrastore.com/company-snapshot/Medicines_Company_The-2109425</link>
<lastBuildDate>08 Nov 2009 06:53:11 EST</lastBuildDate>
<alacra:xlsid>2109425</alacra:xlsid>
<alacra:company>Medicines Company, The</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<item><link>http://www.alacrastore.com/storecontent/newstex/BW-0001-39305901</link><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">BW-0001-39305901</newstex:docid><guid isPermaLink="false">newstex/BW-0001-39305901</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><newstex:Contributor xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Contributor><newstex:CopyrightDate xmlns:newstex="http://www.alacra.com/newstex">2005</newstex:CopyrightDate><newstex:CreditLine xmlns:newstex="http://www.alacra.com/newstex">Zacks.com</newstex:CreditLine><newstex:Provider xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Provider><newstex:ProviderId xmlns:newstex="http://www.alacra.com/newstex">newstex.com</newstex:ProviderId><newstex:PublicIdentifier xmlns:newstex="http://www.alacra.com/newstex">newstexBW-0001-39305901</newstex:PublicIdentifier><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">Business Wire</newstex:Publication><newstex:PublicationCode xmlns:newstex="http://www.alacra.com/newstex">0001</newstex:PublicationCode><newstex:Publisher xmlns:newstex="http://www.alacra.com/newstex">Business Wire</newstex:Publisher><newstex:PublisherCode xmlns:newstex="http://www.alacra.com/newstex">BW</newstex:PublisherCode><newstex:RevisionId xmlns:newstex="http://www.alacra.com/newstex">1</newstex:RevisionId><newstex:Source xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Source><newstex:SourceId xmlns:newstex="http://www.alacra.com/newstex">Business Wire</newstex:SourceId><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04009000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016048</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><pubDate>30 Oct 2009 05:19:22 EST</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18008000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:loaddate xmlns:newstex="http://www.alacra.com/newstex">10/30/2009</newstex:loaddate><title>Zacks Sell List Highlights: The Great Atlantic &amp; Pacific Tea Co., Encore Wire Corp., Pool Corp. and The Medicines Co.</title><description> Oct. ##, #### (Business Wire) --  Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks ## Rank List Â– Stocks to Sell Now. These stocks are currently rated as a Zacks Rank ## (Strong Sell):...</description><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">ENCORE WIRE CORP</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">GREAT ATLANTIC &amp; PACIFIC TEA CO INC</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MEDICINES CO</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">GAJ</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">GAP</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MDCO</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">WIRE</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/B2467932</link><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">B2467932</ccbn:docid><guid isPermaLink="false">ccbn/B2467932</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><pubDate>28 Oct 2009 06:10:13 EST</pubDate><ccbn:eventid xmlns:ccbn="http://www.alacra.com/ccbn">2467932</ccbn:eventid><ccbn:headline xmlns:ccbn="http://www.alacra.com/ccbn">Edited Brief of MDCO earnings conference call or presentation, 28-Oct-09 8:30am ET</ccbn:headline><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">The Medicines Company</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">106.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Edited</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">The Medicines Company Q3 2009 Earnings Conference Call Summary</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MDCO</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">8:30am ET</ccbn:time><title>The Medicines Company Q3 2009 Earnings Conference Call Summary</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Brief</ccbn:type><description>...Robyn Brown The Medicines Company - VP, IR Clive Meanwell The Medicines Company - Chairman and CEO Kim Carroll The Medicines Company - General Manager, Interventional and Emergency Medicines Brent Furse The Medicines Company - VP and General Manager, Interventional and Emergency Medicines Glenn Sblendorio The Medicines Company - EVP and CFO...

</description><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T2467932</link><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T2467932</ccbn:docid><guid isPermaLink="false">ccbn/T2467932</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><pubDate>28 Oct 2009 05:10:14 EST</pubDate><ccbn:eventid xmlns:ccbn="http://www.alacra.com/ccbn">2467932</ccbn:eventid><ccbn:headline xmlns:ccbn="http://www.alacra.com/ccbn">Final Transcript of MDCO earnings conference call or presentation, 28-Oct-09 8:30am ET</ccbn:headline><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">The Medicines Company</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">106.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">The Medicines Company Q3 2009 Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MDCO</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">8:30am ET</ccbn:time><title>The Medicines Company Q3 2009 Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><description>...Robyn Brown The Medicines Company - VP, IR Clive Meanwell The Medicines Company - Chairman and CEO Kim Carroll The Medicines Company - General Manager, Interventional and Emergency Medicines Brent Furse The Medicines Company - VP and General Manager, Interventional and Emergency Medicines Glenn Sblendorio The Medicines Company - EVP and CFO...

</description><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/MW-0001-39219410</link><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">MW-0001-39219410</newstex:docid><guid isPermaLink="false">newstex/MW-0001-39219410</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><newstex:Contributor xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Contributor><newstex:CopyrightDate xmlns:newstex="http://www.alacra.com/newstex">2005</newstex:CopyrightDate><newstex:CopyrightHolder xmlns:newstex="http://www.alacra.com/newstex">Copyright (c) 2009, Marketwire. All rights reserved. All the news releases provided by Market Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited.</newstex:CopyrightHolder><newstex:CreditLine xmlns:newstex="http://www.alacra.com/newstex">The Medicines Company</newstex:CreditLine><newstex:DateLine xmlns:newstex="http://www.alacra.com/newstex">PARSIPPANY, NJ</newstex:DateLine><newstex:Provider xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Provider><newstex:ProviderId xmlns:newstex="http://www.alacra.com/newstex">newstex.com</newstex:ProviderId><newstex:PublicIdentifier xmlns:newstex="http://www.alacra.com/newstex">newstexMW-0001-39219410</newstex:PublicIdentifier><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">Marketwire</newstex:Publication><newstex:PublicationCode xmlns:newstex="http://www.alacra.com/newstex">0001</newstex:PublicationCode><newstex:Publisher xmlns:newstex="http://www.alacra.com/newstex">Marketwire</newstex:Publisher><newstex:PublisherCode xmlns:newstex="http://www.alacra.com/newstex">MW</newstex:PublisherCode><newstex:RevisionId xmlns:newstex="http://www.alacra.com/newstex">1</newstex:RevisionId><newstex:Source xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Source><newstex:SourceId xmlns:newstex="http://www.alacra.com/newstex">Marketwire</newstex:SourceId><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09015000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016048</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016003</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016005</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014012</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014009</newstex:cat><pubDate>28 Oct 2009 09:24:17 EST</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18008000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18020000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18016000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18018000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001000</newstex:geo><newstex:loaddate xmlns:newstex="http://www.alacra.com/newstex">10/28/2009</newstex:loaddate><title>The Medicines Company Reports Third Quarter 2009 Financial Results</title><description> PARSIPPANY, NJ, Oct. ##, #### (Marketwire delivered by Newstex) -- PARSIPPANY, NJ -- (Marketwire) -- ##/##/## --  The Medicines Company (NASDAQ: MDCO) today announced its financial results for the third quarter of ####. Financial highlights...</description><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MEDICINES CO</newstex:index_entry_company><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">CLIVE MEANWELL</newstex:index_entry_person><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MDCO</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/MW-0001-38655585</link><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">MW-0001-38655585</newstex:docid><guid isPermaLink="false">newstex/MW-0001-38655585</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><newstex:Contributor xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Contributor><newstex:CopyrightDate xmlns:newstex="http://www.alacra.com/newstex">2005</newstex:CopyrightDate><newstex:CopyrightHolder xmlns:newstex="http://www.alacra.com/newstex">Copyright (c) 2009, Marketwire. All rights reserved. All the news releases provided by Market Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited.</newstex:CopyrightHolder><newstex:CreditLine xmlns:newstex="http://www.alacra.com/newstex">The Medicines Company</newstex:CreditLine><newstex:DateLine xmlns:newstex="http://www.alacra.com/newstex">PARSIPPANY, NJ</newstex:DateLine><newstex:Provider xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Provider><newstex:ProviderId xmlns:newstex="http://www.alacra.com/newstex">newstex.com</newstex:ProviderId><newstex:PublicIdentifier xmlns:newstex="http://www.alacra.com/newstex">newstexMW-0001-38655585</newstex:PublicIdentifier><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">Marketwire</newstex:Publication><newstex:PublicationCode xmlns:newstex="http://www.alacra.com/newstex">0001</newstex:PublicationCode><newstex:Publisher xmlns:newstex="http://www.alacra.com/newstex">Marketwire</newstex:Publisher><newstex:PublisherCode xmlns:newstex="http://www.alacra.com/newstex">MW</newstex:PublisherCode><newstex:RevisionId xmlns:newstex="http://www.alacra.com/newstex">1</newstex:RevisionId><newstex:Source xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Source><newstex:SourceId xmlns:newstex="http://www.alacra.com/newstex">Marketwire</newstex:SourceId><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016031</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02002008</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014012</newstex:cat><pubDate>08 Oct 2009 06:19:33 EST</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18018000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001000</newstex:geo><newstex:loaddate xmlns:newstex="http://www.alacra.com/newstex">10/8/2009</newstex:loaddate><title>The Medicines Company Files Patent Infringement Lawsuits</title><description> PARSIPPANY, NJ, Oct. #, #### (Marketwire delivered by Newstex) -- PARSIPPANY, NJ -- (Marketwire) -- ##/##/## --  The Medicines Company (NASDAQ: MDCO) today announced that it has filed lawsuits against Teva Parenteral Medicines, Inc.,...</description><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MEDICINES CO</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MDCO</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/MW-0001-38638300</link><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">MW-0001-38638300</newstex:docid><guid isPermaLink="false">newstex/MW-0001-38638300</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><newstex:Contributor xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Contributor><newstex:CopyrightDate xmlns:newstex="http://www.alacra.com/newstex">2005</newstex:CopyrightDate><newstex:CopyrightHolder xmlns:newstex="http://www.alacra.com/newstex">Copyright (c) 2009, Marketwire. All rights reserved. All the news releases provided by Market Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited.</newstex:CopyrightHolder><newstex:CreditLine xmlns:newstex="http://www.alacra.com/newstex">The Medicines Company</newstex:CreditLine><newstex:DateLine xmlns:newstex="http://www.alacra.com/newstex">PARSIPPANY, NJ</newstex:DateLine><newstex:Provider xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Provider><newstex:ProviderId xmlns:newstex="http://www.alacra.com/newstex">newstex.com</newstex:ProviderId><newstex:PublicIdentifier xmlns:newstex="http://www.alacra.com/newstex">newstexMW-0001-38638300</newstex:PublicIdentifier><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">Marketwire</newstex:Publication><newstex:PublicationCode xmlns:newstex="http://www.alacra.com/newstex">0001</newstex:PublicationCode><newstex:Publisher xmlns:newstex="http://www.alacra.com/newstex">Marketwire</newstex:Publisher><newstex:PublisherCode xmlns:newstex="http://www.alacra.com/newstex">MW</newstex:PublisherCode><newstex:RevisionId xmlns:newstex="http://www.alacra.com/newstex">1</newstex:RevisionId><newstex:Source xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Source><newstex:SourceId xmlns:newstex="http://www.alacra.com/newstex">Marketwire</newstex:SourceId><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016031</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02002008</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014012</newstex:cat><pubDate>08 Oct 2009 09:24:58 EST</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18018000</newstex:event><newstex:loaddate xmlns:newstex="http://www.alacra.com/newstex">10/8/2009</newstex:loaddate><title>The Medicines Company Announces Second New Patent Issuance for Angiomax(R)</title><description> PARSIPPANY, NJ, Oct. #, #### (Marketwire delivered by Newstex) -- PARSIPPANY, NJ -- (Marketwire) -- ##/##/## --  The Medicines Company (NASDAQ: MDCO) today announced that the United States Patent and Trademark Office (PTO) issued a...</description><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MEDICINES CO</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MDCO</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/MW-0001-38488877</link><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">MW-0001-38488877</newstex:docid><guid isPermaLink="false">newstex/MW-0001-38488877</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><newstex:Contributor xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Contributor><newstex:CopyrightDate xmlns:newstex="http://www.alacra.com/newstex">2005</newstex:CopyrightDate><newstex:CopyrightHolder xmlns:newstex="http://www.alacra.com/newstex">Copyright (c) 2009, Marketwire. All rights reserved. All the news releases provided by Market Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited.</newstex:CopyrightHolder><newstex:CreditLine xmlns:newstex="http://www.alacra.com/newstex">The Medicines Company</newstex:CreditLine><newstex:DateLine xmlns:newstex="http://www.alacra.com/newstex">PARSIPPANY, NJ</newstex:DateLine><newstex:Provider xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Provider><newstex:ProviderId xmlns:newstex="http://www.alacra.com/newstex">newstex.com</newstex:ProviderId><newstex:PublicIdentifier xmlns:newstex="http://www.alacra.com/newstex">newstexMW-0001-38488877</newstex:PublicIdentifier><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">Marketwire</newstex:Publication><newstex:PublicationCode xmlns:newstex="http://www.alacra.com/newstex">0001</newstex:PublicationCode><newstex:Publisher xmlns:newstex="http://www.alacra.com/newstex">Marketwire</newstex:Publisher><newstex:PublisherCode xmlns:newstex="http://www.alacra.com/newstex">MW</newstex:PublisherCode><newstex:RevisionId xmlns:newstex="http://www.alacra.com/newstex">1</newstex:RevisionId><newstex:Source xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Source><newstex:SourceId xmlns:newstex="http://www.alacra.com/newstex">Marketwire</newstex:SourceId><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09015000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016008</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014012</newstex:cat><pubDate>02 Oct 2009 09:22:28 EST</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18007000</newstex:event><newstex:loaddate xmlns:newstex="http://www.alacra.com/newstex">10/2/2009</newstex:loaddate><title>The Medicines Company Announces the Resignation of Its Chief Operating Officer</title><description> PARSIPPANY, NJ, Oct. #, #### (Marketwire delivered by Newstex) -- PARSIPPANY, NJ -- (Marketwire) -- ##/##/## --  The Medicines Company (NASDAQ: MDCO) today announced the resignation of John P. Kelley as the Company's President and Chief...</description><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MEDICINES CO</newstex:index_entry_company><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">CLIVE MEANWELL</newstex:index_entry_person><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">JOHN P KELLEY</newstex:index_entry_person><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MDCO</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/MW-0001-38383179</link><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">MW-0001-38383179</newstex:docid><guid isPermaLink="false">newstex/MW-0001-38383179</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><newstex:Contributor xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Contributor><newstex:CopyrightDate xmlns:newstex="http://www.alacra.com/newstex">2005</newstex:CopyrightDate><newstex:CopyrightHolder xmlns:newstex="http://www.alacra.com/newstex">Copyright (c) 2009, Marketwire. All rights reserved. All the news releases provided by Market Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited.</newstex:CopyrightHolder><newstex:CreditLine xmlns:newstex="http://www.alacra.com/newstex">The Medicines Company</newstex:CreditLine><newstex:DateLine xmlns:newstex="http://www.alacra.com/newstex">PARSIPPANY, NJ</newstex:DateLine><newstex:Provider xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Provider><newstex:ProviderId xmlns:newstex="http://www.alacra.com/newstex">newstex.com</newstex:ProviderId><newstex:PublicIdentifier xmlns:newstex="http://www.alacra.com/newstex">newstexMW-0001-38383179</newstex:PublicIdentifier><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">Marketwire</newstex:Publication><newstex:PublicationCode xmlns:newstex="http://www.alacra.com/newstex">0001</newstex:PublicationCode><newstex:Publisher xmlns:newstex="http://www.alacra.com/newstex">Marketwire</newstex:Publisher><newstex:PublisherCode xmlns:newstex="http://www.alacra.com/newstex">MW</newstex:PublisherCode><newstex:RevisionId xmlns:newstex="http://www.alacra.com/newstex">1</newstex:RevisionId><newstex:Source xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Source><newstex:SourceId xmlns:newstex="http://www.alacra.com/newstex">Marketwire</newstex:SourceId><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014012</newstex:cat><pubDate>29 Sep 2009 05:28:29 EST</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18022000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18020000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001000</newstex:geo><newstex:loaddate xmlns:newstex="http://www.alacra.com/newstex">9/29/2009</newstex:loaddate><title>The Medicines Company Licenses Innovative New Formulation of Argatroban; Gains Strategic Complement to Angiomax Franchise and Potential Near Term Revenue Opportunity</title><description> PARSIPPANY, NJ, Sep. ##, #### (Marketwire delivered by Newstex) -- PARSIPPANY, NJ -- (Marketwire) -- ##/##/## --  The Medicines Company (NASDAQ: MDCO) today announced that it has entered into a license agreement with Eagle Pharmaceuticals,...</description><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MEDICINES CO</newstex:index_entry_company><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">CLIVE MEANWELL</newstex:index_entry_person><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">GLENN SBLENDORIO</newstex:index_entry_person><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MDCO</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T2457406</link><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T2457406</ccbn:docid><guid isPermaLink="false">ccbn/T2457406</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><pubDate>24 Sep 2009 12:06:00 EST</pubDate><ccbn:eventid xmlns:ccbn="http://www.alacra.com/ccbn">2457406</ccbn:eventid><ccbn:headline xmlns:ccbn="http://www.alacra.com/ccbn">Final Transcript of MDCO presentation, 23-Sep-09 9:00am ET</ccbn:headline><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">The Medicines Company</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">The Medicines Company at UBS Global Life Sciences Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MDCO</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:00am ET</ccbn:time><title>The Medicines Company at UBS Global Life Sciences Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><description>...Andrew Peters - UBS - Analyst/Moderator Good morning. Welcome to the final day of the UBS Global Life Sciences Conference. I am Andrew Peters, and I'm on the biotech team here at UBS. It's my pleasure to introduce The Medicines Company presenting this morning. With us is Mr. John Kelley, President and COO. Immediately following the presentation, there'll be a breakout session downstairs in the Juilliard room. So if you could, please hold your questions to then. With that, let me turn it over to John. John Kelley - The Medicines Co. - President, COO Thank you, Andrew, and thanks to UBS for inviting us to this conference. I want to thank all of you for your interest in The Medicines Company and attending the session this morning. I'm John Kelley. I am the President and Chief Operating Officer of The Medicines Company. During my presentation this morning, I will be making forward-looking statements. There are inherent risks in those statements. I refer you to our recent SEC filings for a more...

</description><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PZM-0001-38009191</link><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PZM-0001-38009191</newstex:docid><guid isPermaLink="false">newstex/PZM-0001-38009191</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><newstex:Contributor xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Contributor><newstex:CopyrightDate xmlns:newstex="http://www.alacra.com/newstex">2005</newstex:CopyrightDate><newstex:CopyrightHolder xmlns:newstex="http://www.alacra.com/newstex">Copyright (c) 2009, GlobeNewswire.</newstex:CopyrightHolder><newstex:CreditLine xmlns:newstex="http://www.alacra.com/newstex">MediciNova, Inc.</newstex:CreditLine><newstex:Provider xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Provider><newstex:ProviderId xmlns:newstex="http://www.alacra.com/newstex">newstex.com</newstex:ProviderId><newstex:PublicIdentifier xmlns:newstex="http://www.alacra.com/newstex">newstexPZM-0001-38009191</newstex:PublicIdentifier><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">GlobeNewswire</newstex:Publication><newstex:PublicationCode xmlns:newstex="http://www.alacra.com/newstex">0001</newstex:PublicationCode><newstex:Publisher xmlns:newstex="http://www.alacra.com/newstex">GlobeNewswire</newstex:Publisher><newstex:PublisherCode xmlns:newstex="http://www.alacra.com/newstex">PZM</newstex:PublisherCode><newstex:RevisionId xmlns:newstex="http://www.alacra.com/newstex">1</newstex:RevisionId><newstex:Source xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Source><newstex:SourceId xmlns:newstex="http://www.alacra.com/newstex">GlobeNewswire</newstex:SourceId><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09015000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016008</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016002</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014012</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010005</newstex:cat><pubDate>16 Sep 2009 07:29:13 EST</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18007000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002013</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002009</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002004</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002007</newstex:geo><newstex:loaddate xmlns:newstex="http://www.alacra.com/newstex">9/16/2009</newstex:loaddate><title>MediciNova, Inc. Appoints Mr. Hiroaki Shigeta to Its Board of Directors</title><description> GlobeNewswire delivered by Newstex) --  SAN DIEGO, Sept. ##, #### (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...</description><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MEDICINES CO</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MEDICINOVA INC</newstex:index_entry_company><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">Hiroaki Shigeta</newstex:index_entry_person><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">Shintaro Asako</newstex:index_entry_person><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">YUICHI IWAKI</newstex:index_entry_person><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MDCO</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MNOV</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/MCOM-0004-37705876</link><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">MCOM-0004-37705876</newstex:docid><guid isPermaLink="false">newstex/MCOM-0004-37705876</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><newstex:Contributor xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Contributor><newstex:CopyrightDate xmlns:newstex="http://www.alacra.com/newstex">2005</newstex:CopyrightDate><newstex:CopyrightHolder xmlns:newstex="http://www.alacra.com/newstex">Copyright (c) M2 Communications Ltd.</newstex:CopyrightHolder><newstex:Provider xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Provider><newstex:ProviderId xmlns:newstex="http://www.alacra.com/newstex">newstex.com</newstex:ProviderId><newstex:PublicIdentifier xmlns:newstex="http://www.alacra.com/newstex">newstexMCOM-0004-37705876</newstex:PublicIdentifier><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">M2 EquityBites</newstex:Publication><newstex:PublicationCode xmlns:newstex="http://www.alacra.com/newstex">0004</newstex:PublicationCode><newstex:Publisher xmlns:newstex="http://www.alacra.com/newstex">M2 Communications Ltd.</newstex:Publisher><newstex:PublisherCode xmlns:newstex="http://www.alacra.com/newstex">MCOM</newstex:PublisherCode><newstex:RevisionId xmlns:newstex="http://www.alacra.com/newstex">1</newstex:RevisionId><newstex:Source xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Source><newstex:SourceId xmlns:newstex="http://www.alacra.com/newstex">M2</newstex:SourceId><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016031</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02002008</newstex:cat><pubDate>03 Sep 2009 11:23:53 EST</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18018000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001000</newstex:geo><newstex:loaddate xmlns:newstex="http://www.alacra.com/newstex">9/3/2009</newstex:loaddate><title>The Medicines Company issues new patent ('727 patent) for Angiomax</title><description> Sep. #, #### (M# Communications Ltd. delivered by Newstex) -- Medicine company The Medicines Company (NASDAQ:MDCO) declared on Wednesday the issuance of a new U.S. patent No. #,###,### ('### patent) for more a consistent and improved...</description><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MEDICINES CO</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MDCO</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/MW-0001-37668712</link><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">MW-0001-37668712</newstex:docid><guid isPermaLink="false">newstex/MW-0001-37668712</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><newstex:Contributor xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Contributor><newstex:CopyrightDate xmlns:newstex="http://www.alacra.com/newstex">2005</newstex:CopyrightDate><newstex:CopyrightHolder xmlns:newstex="http://www.alacra.com/newstex">Copyright (c) 2009, Marketwire. All rights reserved. All the news releases provided by Market Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited.</newstex:CopyrightHolder><newstex:CreditLine xmlns:newstex="http://www.alacra.com/newstex">The Medicines Company</newstex:CreditLine><newstex:DateLine xmlns:newstex="http://www.alacra.com/newstex">PARSIPPANY, NJ</newstex:DateLine><newstex:Provider xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Provider><newstex:ProviderId xmlns:newstex="http://www.alacra.com/newstex">newstex.com</newstex:ProviderId><newstex:PublicIdentifier xmlns:newstex="http://www.alacra.com/newstex">newstexMW-0001-37668712</newstex:PublicIdentifier><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">Marketwire</newstex:Publication><newstex:PublicationCode xmlns:newstex="http://www.alacra.com/newstex">0001</newstex:PublicationCode><newstex:Publisher xmlns:newstex="http://www.alacra.com/newstex">Marketwire</newstex:Publisher><newstex:PublisherCode xmlns:newstex="http://www.alacra.com/newstex">MW</newstex:PublisherCode><newstex:RevisionId xmlns:newstex="http://www.alacra.com/newstex">1</newstex:RevisionId><newstex:Source xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Source><newstex:SourceId xmlns:newstex="http://www.alacra.com/newstex">Marketwire</newstex:SourceId><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016031</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02002008</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014012</newstex:cat><pubDate>02 Sep 2009 02:48:16 EST</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18018000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001000</newstex:geo><newstex:loaddate xmlns:newstex="http://www.alacra.com/newstex">9/2/2009</newstex:loaddate><title>The Medicines Company Announces New Patent Issuance for Angiomax(R)</title><description> PARSIPPANY, NJ, Sep. #, #### (Marketwire delivered by Newstex) -- PARSIPPANY, NJ -- (Marketwire) -- ##/##/## --  The Medicines Company (NASDAQ: MDCO) today announced that the United States Patent and Trademark Office (PTO) issued a...</description><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MEDICINES CO</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MDCO</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/BW-0001-37240819</link><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">BW-0001-37240819</newstex:docid><guid isPermaLink="false">newstex/BW-0001-37240819</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><newstex:Contributor xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Contributor><newstex:CopyrightDate xmlns:newstex="http://www.alacra.com/newstex">2005</newstex:CopyrightDate><newstex:CreditLine xmlns:newstex="http://www.alacra.com/newstex">Tongjitang Chinese Medicines Company</newstex:CreditLine><newstex:Provider xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Provider><newstex:ProviderId xmlns:newstex="http://www.alacra.com/newstex">newstex.com</newstex:ProviderId><newstex:PublicIdentifier xmlns:newstex="http://www.alacra.com/newstex">newstexBW-0001-37240819</newstex:PublicIdentifier><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">Business Wire</newstex:Publication><newstex:PublicationCode xmlns:newstex="http://www.alacra.com/newstex">0001</newstex:PublicationCode><newstex:Publisher xmlns:newstex="http://www.alacra.com/newstex">Business Wire</newstex:Publisher><newstex:PublisherCode xmlns:newstex="http://www.alacra.com/newstex">BW</newstex:PublisherCode><newstex:RevisionId xmlns:newstex="http://www.alacra.com/newstex">1</newstex:RevisionId><newstex:Source xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Source><newstex:SourceId xmlns:newstex="http://www.alacra.com/newstex">Business Wire</newstex:SourceId><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09015000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016048</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016003</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04010000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04010001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04006000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04006005</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014012</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003005</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010005</newstex:cat><pubDate>14 Aug 2009 06:21:54 EST</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18008000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18020000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002004</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002009</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002013</newstex:geo><newstex:loaddate xmlns:newstex="http://www.alacra.com/newstex">8/14/2009</newstex:loaddate><title>Tongjitang Chinese Medicines Company Reports Second Quarter 2009 Financial Results</title><description> Aug. ##, #### (Business Wire) --  Tongjitang Chinese Medicines Company (NYSE: TCM) (Â“TongjitangÂ” or the Â“CompanyÂ”), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized...</description><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MEDICINES CO</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">TONGJITANG CHINESE MEDICINES COMPANY</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MDCO</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">TCM</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/BW-0001-37156890</link><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">BW-0001-37156890</newstex:docid><guid isPermaLink="false">newstex/BW-0001-37156890</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><newstex:Contributor xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Contributor><newstex:CopyrightDate xmlns:newstex="http://www.alacra.com/newstex">2005</newstex:CopyrightDate><newstex:CreditLine xmlns:newstex="http://www.alacra.com/newstex">Tongjitang Chinese Medicines Company</newstex:CreditLine><newstex:Provider xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Provider><newstex:ProviderId xmlns:newstex="http://www.alacra.com/newstex">newstex.com</newstex:ProviderId><newstex:PublicIdentifier xmlns:newstex="http://www.alacra.com/newstex">newstexBW-0001-37156890</newstex:PublicIdentifier><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">Business Wire</newstex:Publication><newstex:PublicationCode xmlns:newstex="http://www.alacra.com/newstex">0001</newstex:PublicationCode><newstex:Publisher xmlns:newstex="http://www.alacra.com/newstex">Business Wire</newstex:Publisher><newstex:PublisherCode xmlns:newstex="http://www.alacra.com/newstex">BW</newstex:PublisherCode><newstex:RevisionId xmlns:newstex="http://www.alacra.com/newstex">1</newstex:RevisionId><newstex:Source xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Source><newstex:SourceId xmlns:newstex="http://www.alacra.com/newstex">Business Wire</newstex:SourceId><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016048</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003005</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014012</newstex:cat><pubDate>12 Aug 2009 10:24:59 EST</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18008000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002004</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002009</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002013</newstex:geo><newstex:loaddate xmlns:newstex="http://www.alacra.com/newstex">8/12/2009</newstex:loaddate><title>Tongjitang Chinese Medicines Company to Announce Second Quarter 2009 Financial Results on August 17, 2009</title><description> Aug. ##, #### (Business Wire) --  Tongjitang Chinese Medicines Company (NYSE: TCM) (Â“TongjitangÂ” or the Â“CompanyÂ”), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized...</description><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MEDICINES CO</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">TONGJITANG CHINESE MEDICINES COMPANY</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MDCO</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">TCM</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/B2295524</link><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">B2295524</ccbn:docid><guid isPermaLink="false">ccbn/B2295524</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><pubDate>29 Jul 2009 05:08:00 EST</pubDate><ccbn:eventid xmlns:ccbn="http://www.alacra.com/ccbn">2295524</ccbn:eventid><ccbn:headline xmlns:ccbn="http://www.alacra.com/ccbn">Edited Brief of MDCO earnings conference call or presentation, 29-Jul-09 8:30am ET</ccbn:headline><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">The Medicines Company</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Edited</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">The Medicines Company Q2 2009 Earnings Conference Call Summary</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MDCO</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">8:30am ET</ccbn:time><title>The Medicines Company Q2 2009 Earnings Conference Call Summary</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Brief</ccbn:type><description>...Lucy Lu Citi Investment Research - Analyst Liana Moussatos Wedbush Morgan Securities - Analyst Jason Kantor RBC Capital Markets - Analyst Joseph Schwartz Leerink Swann &amp; Co. - Analyst Maged Shenouda UBS - Analyst OVERVIEW...

</description><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T2295524</link><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T2295524</ccbn:docid><guid isPermaLink="false">ccbn/T2295524</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><pubDate>29 Jul 2009 11:08:00 EST</pubDate><ccbn:eventid xmlns:ccbn="http://www.alacra.com/ccbn">2295524</ccbn:eventid><ccbn:headline xmlns:ccbn="http://www.alacra.com/ccbn">Final Transcript of MDCO earnings conference call or presentation, 29-Jul-09 8:30am ET</ccbn:headline><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">The Medicines Company</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">The Medicines Company Q2 2009 Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MDCO</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">8:30am ET</ccbn:time><title>The Medicines Company Q2 2009 Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><description>...Lucy Lu Citi Investment Research - Analyst Liana Moussatos Wedbush Morgan Securities - Analyst Jason Kantor RBC Capital Markets - Analyst Joseph Schwartz Leerink Swann &amp; Co. - Analyst Maged Shenouda UBS - Analyst P R E S E N T A T I O N...

</description><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T2176160</link><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T2176160</ccbn:docid><guid isPermaLink="false">ccbn/T2176160</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><pubDate>19 May 2009 11:07:00 EST</pubDate><ccbn:eventid xmlns:ccbn="http://www.alacra.com/ccbn">2176160</ccbn:eventid><ccbn:headline xmlns:ccbn="http://www.alacra.com/ccbn">Final Transcript of MDCO presentation, 18-May-09 10:00am ET</ccbn:headline><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">The Medicines Company</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">The Medicines Company at Deutsche Bank Healthcare Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MDCO</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">10:00am ET</ccbn:time><title>The Medicines Company at Deutsche Bank Healthcare Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><description>...Robyn Karnauskas Deutsche Bank - Analyst Clive Meanwell The Medicines Company - Chairman and Chief Executive Officer P R E S E N T A T I O N...

</description><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/B2222344</link><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">B2222344</ccbn:docid><guid isPermaLink="false">ccbn/B2222344</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><pubDate>13 May 2009 11:06:00 EST</pubDate><ccbn:eventid xmlns:ccbn="http://www.alacra.com/ccbn">2222344</ccbn:eventid><ccbn:headline xmlns:ccbn="http://www.alacra.com/ccbn">Edited Brief of MDCO conference call or presentation, 13-May-09 8:30am ET</ccbn:headline><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">The Medicines Company</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Edited</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program of Cangrelor Conference Call Summary</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MDCO</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">8:30am ET</ccbn:time><title>The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program of Cangrelor Conference Call Summary</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Brief</ccbn:type><description>...Joseph Schwartz Leerink Swann - Analyst Liana Moussatos Wedbush Morgan - Analyst Jason Kantor RBC Capital Markets - Analyst Maged Shenouda UBS - Analyst Lucy Lu Citigroup - Analyst OVERVIEW...

</description><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T2222344</link><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T2222344</ccbn:docid><guid isPermaLink="false">ccbn/T2222344</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><pubDate>13 May 2009 11:06:00 EST</pubDate><ccbn:eventid xmlns:ccbn="http://www.alacra.com/ccbn">2222344</ccbn:eventid><ccbn:headline xmlns:ccbn="http://www.alacra.com/ccbn">Final Transcript of MDCO conference call or presentation, 13-May-09 8:30am ET</ccbn:headline><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">The Medicines Company</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program of Cangrelor Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MDCO</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">8:30am ET</ccbn:time><title>The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program of Cangrelor Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><description>...Joseph Schwartz Leerink Swann - Analyst Liana Moussatos Wedbush Morgan - Analyst Jason Kantor RBC Capital Markets - Analyst Maged Shenouda UBS - Analyst Lucy Lu Citigroup - Analyst P R E S E N T A T I O N...

</description><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/bir/757011</link><bir:docid xmlns:bir="http://www.alacra.com/bir">757011</bir:docid><guid isPermaLink="false">bir/757011</guid><bir:index_mode xmlns:bir="http://www.alacra.com/bir">norm</bir:index_mode><bir:class xmlns:bir="http://www.alacra.com/bir">17</bir:class><bir:company xmlns:bir="http://www.alacra.com/bir">Medicines Co.</bir:company><bir:company xmlns:bir="http://www.alacra.com/bir">The Medicines Co.</bir:company><bir:cou xmlns:bir="http://www.alacra.com/bir">United States</bir:cou><pubDate>12 May 2009 06:22:00 EST</pubDate><bir:descr xmlns:bir="http://www.alacra.com/bir">Manufacturing: Manufactures pharmaceutical preparations.</bir:descr><bir:exch xmlns:bir="http://www.alacra.com/bir">NASDAQ</bir:exch><bir:naics xmlns:bir="http://www.alacra.com/bir">325412</bir:naics><bir:revenue xmlns:bir="http://www.alacra.com/bir">I</bir:revenue><bir:sic xmlns:bir="http://www.alacra.com/bir">2834</bir:sic><bir:size xmlns:bir="http://www.alacra.com/bir">D</bir:size><bir:ticker xmlns:bir="http://www.alacra.com/bir">MDCO</bir:ticker><title>Medicines Co.</title><description>Manufacturing: Manufactures pharmaceutical preparations.</description><category>Company Profiles &amp; Financials</category><alacra:ip>Gale Company Profiles</alacra:ip></item></channel></rss>